PRELUDE THERAPEUTICS INC COM is a security (CUSIP 74065P101) tracked across SEC portfolio filings. 58 institutional managers reported $102.9M on Form 13F as of 2026-06-30; 6 registered fund positions totaling $1.1M via N-PORT as of 2026-05-29.
Showing 15 of 58 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| ORBIMED ADVISORS LLC | New York, NY | $37.3M | 10,909,256 |
| BAKER BROS. ADVISORS LP | NEW YORK, NY | $34.6M | 10,123,824 |
| Kynam Capital Management, LP | PRINCETON, NJ | $5.4M | 1,592,551 |
| VANGUARD GROUP INC | Valley Forge, PA | $4.1M | 1,413,986 |
| EcoR1 Capital, LLC | San Francisco, CA | $3.2M | 947,049 |
| TWO SIGMA INVESTMENTS, LP | New York, NY | $3.2M | 923,626 |
| SPHERA FUNDS MANAGEMENT LTD. | TEL AVIV, L3 | $1.9M | 558,339 |
| MILLENNIUM MANAGEMENT LLC | NEW YORK, NY | $1.3M | 382,737 |
| MARSHALL WACE, LLP | LONDON, X0 | $1.2M | 358,906 |
| MORGAN STANLEY | NEW YORK, NY | $1.1M | 322,161 |
| BlackRock, Inc. | New York, NY | $1.1M | 321,886 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $1.0M | 302,458 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | BALA CYNWYD, PA | $988K | 267,788 |
| RENAISSANCE TECHNOLOGIES LLC | NEW YORK, NY | $941K | 275,200 |
| GOLDMAN SACHS GROUP INC | NEW YORK, NY | $809K | 236,469 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $900K | 0.11% |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | VANGUARD INSTITUTIONAL INDEX FUNDS | $63K | 0.02% |
| U.S. MICRO CAP PORTFOLIO | DFA INVESTMENT DIMENSIONS GROUP INC | $45K | 0.06% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $44K | 0.01% |
| Blackstone Alternative Multi-Strategy Fund | Blackstone Alternative Investment Funds | $20K | 0.06% |
| Guggenheim Active Allocation Fund | Guggenheim Active Allocation Fund | $251 | 0.00% |